Literature DB >> 27078056

Design of tuberculosis vaccine trials under financial constraints.

Alberto L García-Basteiro1,2,3, Morten Ruhwald4, Christoph Lange5,6,7,8,9.   

Abstract

Entities:  

Keywords:  BCG; R&D; Tuberculosis; correlates of protection; vaccine

Mesh：

Substances：

Year:  2016        PMID： 27078056     DOI： 10.1080/14760584.2016.1178067

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  3 in total

1.  Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis.

Authors:  Christina Jensen; Line Lindebo Holm; Erik Svensson; Claus Aagaard; Morten Ruhwald
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

2.  A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo.

Authors:  Line L Holm; Milica Vukmanovic-Stejic; Thomas Blauenfeldt; Thomas Benfield; Peter Andersen; Arne N Akbar; Morten Ruhwald
Journal:  J Vis Exp       Date:  2018-08-11       Impact factor: 1.355

Review 3.  Clinical Development of New TB Vaccines: Recent Advances and Next Steps.

Authors:  Mark Hatherill; Richard G White; Thomas R Hawn
Journal:  Front Microbiol       Date:  2020-01-30       Impact factor: 5.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.